328 related articles for article (PubMed ID: 30591391)
1. Photobiomodulation with low-level laser therapy reduces oral mucositis caused by head and neck radio-chemotherapy: prospective randomized controlled trial.
Marín-Conde F; Castellanos-Cosano L; Pachón-Ibañez J; Serrera-Figallo MA; Gutiérrez-Pérez JL; Torres-Lagares D
Int J Oral Maxillofac Surg; 2019 Jul; 48(7):917-923. PubMed ID: 30591391
[TBL] [Abstract][Full Text] [Related]
2. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
[TBL] [Abstract][Full Text] [Related]
3. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
5. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation.
Antunes HS; Schluckebier LF; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Rampini MP; Ferreira EM; Dias FL; Teich V; Teich N; Ferreira CG
Oral Oncol; 2016 Jan; 52():85-90. PubMed ID: 26559740
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients.
He M; Zhang B; Shen N; Wu N; Sun J
Eur J Pediatr; 2018 Jan; 177(1):7-17. PubMed ID: 29128883
[TBL] [Abstract][Full Text] [Related]
8. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial.
Kauark-Fontes E; Migliorati CA; Epstein JB; Treister NS; Alves CGB; Faria KM; Palmier NR; Rodrigues-Oliveira L; de Pauli Paglioni M; Gueiros LAM; da Conceição Vasconcelos KGM; de Castro G; Leme AFP; Lopes MA; Prado-Ribeiro AC; Brandão TB; Santos-Silva AR
Support Care Cancer; 2022 Mar; 30(3):2225-2236. PubMed ID: 34708311
[TBL] [Abstract][Full Text] [Related]
9. Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma.
Palmieri M; Martins VAO; Sumita LM; Tozetto-Mendoza TR; Romano BB; Machado CM; Pannuti CS; Brandão TB; Ribeiro ACP; Corrêa L; Braz-Silva PH
Clin Oral Investig; 2017 Sep; 21(7):2291-2301. PubMed ID: 27966015
[TBL] [Abstract][Full Text] [Related]
10. Low-level laser or LED photobiomodulation on oral mucositis in pediatric patients under high doses of methotrexate: prospective, randomized, controlled trial.
Guimaraes DM; Ota TMN; Da Silva DAC; Almeida FLDS; Schalch TD; Deana AM; Junior JMA; Fernandes KPS
Support Care Cancer; 2021 Nov; 29(11):6441-6447. PubMed ID: 33893842
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.
Oton-Leite AF; Silva GB; Morais MO; Silva TA; Leles CR; Valadares MC; Pinezi JC; Batista AC; Mendonça EF
Lasers Surg Med; 2015 Apr; 47(4):296-305. PubMed ID: 25824475
[TBL] [Abstract][Full Text] [Related]
12. Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial.
Ferretti GA; Raybould TP; Brown AT; Macdonald JS; Greenwood M; Maruyama Y; Geil J; Lillich TT; Ash RC
Oral Surg Oral Med Oral Pathol; 1990 Mar; 69(3):331-8. PubMed ID: 2179802
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy mucositis in head and neck cancer: prevention by low-energy surface laser.
Bourbonne V; Otz J; Bensadoun RJ; Dissaux G; Lucia F; Leclere JC; Pradier O; Schick U
BMJ Support Palliat Care; 2022 Dec; 12(e6):e838-e845. PubMed ID: 31527154
[TBL] [Abstract][Full Text] [Related]
14. [Use of laser for the prevention and treatment of oral mucositis induced by radiotherapy and chemotherapy for head and neck cancer].
Muñoz-Corcuera M; González-Nieto A; López-Pintor Muñoz RM
Med Clin (Barc); 2014 Aug; 143(4):170-5. PubMed ID: 24216016
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of preventive laser photobiomodulation in patients with head and neck cancer undergoing radiochemotherapy: Laser in patients with head and neck cancer.
Dantas JBL; Martins GB; Lima HR; Carrera M; Reis SRA; Medrado ARAP
Spec Care Dentist; 2020 Jul; 40(4):364-373. PubMed ID: 32544269
[TBL] [Abstract][Full Text] [Related]
16. Adherence of head and neck cancer patients to laser photobiomodulation in a public health service: Pilot study.
da Costa JDR; de Lima Dantas JB; Martins GB; Carrera M; de Almeida Reis SR; Medrado ARAP
Complement Ther Med; 2021 May; 58():102687. PubMed ID: 33610725
[TBL] [Abstract][Full Text] [Related]
17. Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis.
Campos TM; do Prado Tavares Silva CA; Sobral APT; Sobral SS; Rodrigues MFSD; Bussadori SK; Fernandes KPS; Mesquita-Ferrari RA; Horliana ACRT; Motta LJ
Support Care Cancer; 2020 Dec; 28(12):5649-5659. PubMed ID: 32666214
[TBL] [Abstract][Full Text] [Related]
18. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
19. Three photobiomodulation protocols in the prevention/treatment of radiotherapy-induced oral mucositis.
de Carvalho PAG; Lessa RC; Carraro DM; Assis Pellizzon AC; Jaguar GC; Alves FA
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101906. PubMed ID: 32619713
[TBL] [Abstract][Full Text] [Related]
20. [Effect of "Xinjingjie mouthrinse" on prevention and treatment of radiation-induced oral mucositis].
Xu XL; Ye C; Zhang L; Li RR; Shao ZY; Tu WY
Shanghai Kou Qiang Yi Xue; 2014 Dec; 23(6):727-30. PubMed ID: 25636291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
